Pricing Log in Create free account

Aytu BioPharma, Inc. (AYTU) vs Bright Green Corporation (BGXXQ)

Aytu BioPharma, Inc. and Bright Green Corporation are both Drug Manufacturers Specialty & Generic companies. Aytu BioPharma, Inc. is the larger, with a market value of $21.8M against $13.9M — 1.6× the size. Bright Green Corporation has the higher net margin (0.00% vs −24.8%) and the lower return on invested capital (−39.4% vs −20.0%). Across the 13 metrics below, Aytu BioPharma, Inc. leads on 7 and Bright Green Corporation on 6.

Valuation

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 0.44 n/m 2.11
P/B 0.71 n/m 1.78
Price to free cash flow 7.77 n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.28 n/m 2.73
Earnings yield (67.16%) 0.00% (4.38%)
Free cash flow yield 12.87% 0.00% 0.00%

Profitability

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Gross margin 63.95% 0.00% 53.94%
Operating margin (14.44%) 0.00% 0.00%
Net margin (24.76%) 0.00% 0.00%
Free cash flow margin 5.62% 0.00% 0.00%
Return on equity (52.55%) (73.60%) (0.40%)
Return on assets (12.44%) (44.80%) (3.32%)
Return on invested capital (19.99%) (39.35%) 0.00%

Growth

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) — 10.01%
EPS growth (last fiscal year) 46.30% 58.82% 49.06%
Revenue growth, 5-year CAGR (2.59%) — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 0.07 0.05
Current ratio 1.13 0.01 2.31
Net debt to EBITDA 2.17 (0.02) 0.97

Dividend

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Market cap 21.84m 13.88m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack